Compounds > azacitidine

azacitidine and Brill-Symmers Disease

azacitidine has been researched along with Brill-Symmers Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bin, Z; Guoliang, H; Hongmei, N; Jiangwei, H; Jianlin, C; Liangding, H; Yao, S; Yuhang, L; Zhuoqing, Q1
Fukuhara, S; Kobayashi, Y; Maeshima, AM; Makita, S; Maruyama, D; Munakata, W; Taniguchi, H; Tobinai, K; Toyoda, K; Watabe, D; Yamauchi, N1
Hiraga, J; Kagami, Y; Narita, M; Suzuki, N; Takagi, Y; Tomita, A1
Ito, S; Ohigashi, H; Shiratori, S; Teshima, T; Tsutsumi, Y1

Other Studies

4 other study(ies) available for azacitidine and Brill-Symmers Disease

ArticleYear
Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Combined Modality Therapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Male; Middle Aged; Myelodysplastic Syndromes; Transplantation, Homologous

2021
Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome.
    The Journal of international medical research, 2017, Volume: 45, Issue:2

    Topics: Acute Lung Injury; Adrenal Cortex Hormones; Aged; Antimetabolites, Antineoplastic; Azacitidine; Humans; Lymphoma, Follicular; Male; Myelodysplastic Syndromes; Prednisolone; Tomography, X-Ray Computed

2017
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
    Annals of hematology, 2018, Volume: 97, Issue:11

    Topics: Antigens, CD20; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine

2018
5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report.
    Journal of medical case reports, 2016, Feb-02, Volume: 10

    Topics: Aged; Antigens, CD20; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Myelodysplastic Syndromes; Rituximab; Up-Regulation

2016